Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan

Clicks: 350
ID: 272946
2002
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #119 of 545 articles by views in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 545 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Resistance among uropathogenic Escherichia coli to trimethoprim-sulfamethoxazole (TMP-SMX) has increased. Risk factors for resistance and the impact on clinical failure have been poorly described. We performed a retrospective cohort study of women with acute uncomplicated cystitis seen at a universi …
Reference Key
pd2002clinicalprevalence Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Brown PD;Freeman A;Foxman B;;
Journal Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Year 2002
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/11914994
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine treatment outcome research support non-u.s. gov't adult female adolescent aged middle aged risk factors Retrospective Studies Bacterial drug resistance Cohort Studies escherichia coli / isolation & purification drug combinations anti-infective agents urinary / pharmacology* urinary tract infections / drug therapy urinary tract infections / microbiology* escherichia coli / drug effects* prevalence escherichia coli infections / microbiology* michigan / epidemiology sulfamethoxazole / therapeutic use trimethoprim / therapeutic use urinary tract infections / epidemiology escherichia coli infections / epidemiology pmid:11914994 doi:10.1086/339491 patricia d brown alison freeman betsy foxman urinary / therapeutic use escherichia coli infections / drug therapy sulfamethoxazole / pharmacology* trimethoprim / pharmacology*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.